Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.33 USD | +1.86% | +1.62% | +47.92% |
Financials (USD)
Sales 2024 * | 6.39B | Sales 2025 * | 6.47B | Capitalization | 5.49B |
---|---|---|---|---|---|
Net income 2024 * | 751M | Net income 2025 * | 971M | EV / Sales 2024 * | 2.05 x |
Net Debt 2024 * | 7.64B | Net Debt 2025 * | 6.93B | EV / Sales 2025 * | 1.92 x |
P/E ratio 2024 * |
7.36
x | P/E ratio 2025 * |
5.69
x | Employees | 10,000 |
Yield 2024 * |
5.21% | Yield 2025 * |
5.42% | Free-Float | 99.84% |
Latest transcript on Organon & Co.
1 day | +1.86% | ||
1 week | +1.62% | ||
1 month | +14.62% | ||
3 months | +22.52% | ||
6 months | +88.43% | ||
Current year | +47.92% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Ali
CEO | Chief Executive Officer | 63 | 21-06-01 |
Matthew Walsh
DFI | Director of Finance/CFO | 57 | 21-06-01 |
Chief Tech/Sci/R&D Officer | 54 | 23-09-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rochelle Lazarus
BRD | Director/Board Member | 76 | 21-06-01 |
Carrie Cox
CHM | Chairman | 66 | 21-06-01 |
Robert Essner
BRD | Director/Board Member | 76 | 21-06-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
15.92% | 254 M€ | +13.69% | - | |
1.71% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 21.33 | +1.86% | 1,980,996 |
24-05-30 | 20.94 | +1.80% | 1,782,985 |
24-05-29 | 20.57 | -1.95% | 1,447,206 |
24-05-28 | 20.98 | -0.05% | 1,190,903 |
24-05-24 | 20.99 | -1.69% | 1,043,753 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.92% | 5.49B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- OGN Stock